Investigator_Profili..

Investigator Profiling and Mapping:
A New, Free Tool
Pharma CI Barcelona
February 18th, 2014
© 2011 The Larvol Group LLC
|
Introduction
Our Clients
Our Team
Core Services
Serving the
healthcare industry
since 2004
(>100 staff)
2/3 of team hold
MDs or PhDs
Customized market
reports based on
secondary data
Clients include
Fortune Global 500
companies,
9 of the top 10
pharma companies
Expertise across all
the major
therapeutic areas:
oncology,
immunology, CNS,
CV/metabolic, etc.
Oncologist Support
Services
Chart Review
Secondary Data
Support
CONFIDENTIAL AND PROPRIETARY
©©2013
2011The
TheLarvol
LarvolGroup,
Group LLC
| 2
Objective of Presentation
Explore the current landscape of public domain data for Investigator/KOL
profiling and mapping
Introduce Larvol Sigma, an open access tool for Investigator/KOL
identification and profiling by disease indication and company/product
associations
©©2013
2011The
TheLarvol
LarvolGroup,
Group LLC
| 3
3
Part I
Explore the current landscape of public domain data for Investigator/KOL
profiling and mapping
Introduce Larvol Sigma, an open access tool for Investigator/KOL
identification and profiling by disease indication and company/product
associations
©©2013
2011The
TheLarvol
LarvolGroup,
Group LLC
| 4
4
Public Investigator/KOL Data Sources
Clinical Trial Databases
Publication Resources
Gov’t Funding Records
Conference Proceedings
©©2013
2011The
TheLarvol
LarvolGroup,
Group LLC
| 5
Sunshine Act Database
  Drug, device, and biological companies obligated to report all
payments made to physicians and teaching hospitals to the Centers
of Medicare and Medicaid Services (CMS)
  Data collection requirements began August 1st, 2013, with report
submission due to CMS by March 31st, 2014.
  Disclosure of reports on public website by September 30th, 2014,
  Database required to be “easily searchable” by maufacturer,
physician, and teaching hospital
©©2013
2011The
TheLarvol
LarvolGroup,
Group LLC
| 6
Microsoft vs Google
©©2013
2011The
TheLarvol
LarvolGroup,
Group LLC
| 7
Commercial Investigator Databases
Name
# Investigators / Source Data
Thomson Reuters
100-500,000 / MEDLINE, BIOSYS, ISI Proceedings
BioPharm Clinical
450,000 / ClinicalTrials.gov, EudraCT, other proprietary
Citeline Sitetrove
300,000 / ClinicalTrials.gov, literature, advertising, other proprietary
Evaluate Group
128,000 / ClinicalTrials.gov
©©2013
2011The
TheLarvol
LarvolGroup,
Group LLC
| 8
Part II
Explore the current landscape of public domain data for Investigator/KOL
profiling and mapping
Introduce Larvol Sigma, an open access tool for Investigator/KOL
identification and profiling by disease indication and company/product
associations
©©2013
2011The
TheLarvol
LarvolGroup,
Group LLC
| 9
9
Larvol Sigma
151,000 Trials
(ClinicalTrials.gov)
6000+ Products
2000+ Companies
900+ MOAs
4000+ Diseases
60,000 Investigators
©©2013
2011The
TheLarvol
LarvolGroup,
Group LLC
| 10
THANK YOU For further enquires:
United States :
Europe:
Bruno Larvol
Natalie Gulley
[email protected]
[email protected]
©©2013
2011The
TheLarvol
LarvolGroup,
Group LLC
| 11
Larvol Sigma: Home Page
©©2013
2011The
TheLarvol
LarvolGroup,
Group LLC
| 12
Larvol Sigma: Investigators by Indication
©©2013
2011The
TheLarvol
LarvolGroup,
Group LLC
| 13
Larvol Sigma: Investigators by Drug MOA
Investigators by Drug MOA
©©2013
2011The
TheLarvol
LarvolGroup,
Group LLC
| 14
Larvol Sigma: Investigators by Product
©©2013
2011The
TheLarvol
LarvolGroup,
Group LLC
| 15
Larvol Sigma: Investigators by Company
©©2013
2011The
TheLarvol
LarvolGroup,
Group LLC
| 16

Download Report